Hematology NewsFrailty-adjusted treatment strategy emerges in myelomaDecember 21, 2018Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsCheckmate 436: Two-drug combo is ‘promising’ for PMBCLDecember 21, 2018Aggressive LymphomasLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsLack of gut diversity hurts survival after HCTDecember 21, 2018Cellular TherapyPatient & Survivor Care
Hematology NewsECHELON-2: BV-CHP boosts survival in PTCLDecember 20, 2018T Cell LymphomasAggressive LymphomasLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsGO-8: Early promise for novel FVIII variant in hemophilia ADecember 20, 2018Bleeding DisordersGene Therapy
Hematology NewsHematologists are outliers in care at the end of lifeDecember 20, 2018Patient & Survivor Care
Oncology PracticeModerate approach best for NET liver metsDecember 20, 2018GastroenterologyGastrointestinal Cancer
Oncology PracticeQOL is poorer for young women after mastectomy than BCSDecember 18, 2018Breast CancerPatient & Survivor Care
Oncology PracticeData underscore the importance of lifestyle interventions in breast cancer patientsDecember 17, 2018Patient & Survivor CareBreast Cancer
The Sarcoma JournalReports from the annual meeting of The Connective Tissue Oncology Society held in Rome, November 14-17, 2018 Sarcoma of the Year: Intimal SarcomaDecember 17, 2018Rare SarcomasSarcoma & GIST
Oncology PracticeExtended AI therapy reduces breast cancer recurrence risk, ups fracture riskDecember 14, 2018Breast Cancer
Oncology PracticeOxybutynin rapidly quells hot flashesDecember 14, 2018Breast CancerPatient & Survivor Care
Hematology NewsPhase 3 data support apixaban for cancer-associated VTEDecember 13, 2018Patient & Survivor CareThrombosis
